A08AB01 |
orlistat
|
Orlistat
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AX |
Other antiobesity drugs
|
Autres médicaments anti obésité
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AX01 |
rimonabant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA |
Enzyme preparations
|
Enzyme - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA01 |
diastase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA02 |
multienzymes (lipase, protease etc.)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA03 |
pepsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA04 |
tilactase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB |
Acid preparations
|
Acide - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB01 |
glutamic acid hydrochloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB02 |
betaine hydrochloride
|
Chlorhydrate de bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB03 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB04 |
citric acid
|
Acide citrique
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AC |
Enzyme and acid preparations, combinations
|
Enzyme et acide - préparations en combinaiso
|
WHO |
Active |
2021-10-25 19:07:13 |
A09AC01 |
pepsin and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AC02 |
multienzymes and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB |
Insulins and analogues for injection, fast-acting
|
Insulines et analogues pour injection, à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB06 |
insulin glulisine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC |
Insulins and analogues for injection, intermediate-acting
|
Insulines et analogues pour injection, à action intermédiaire
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD |
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
|
Insulines et analogues pour injection, à action intermédiaire ou longue combinées avec insulines à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD06 |
insulin degludec and insulin aspart
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE |
Insulins and analogues for injection, long-acting
|
Insulines et analogues pour injection, à action lent
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE04 |
insulin glargine
|
Insuline glargine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE05 |
insulin detemir
|
Insuline détemir
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE06 |
insulin degludec
|
Insuline dégludec
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE54 |
insulin glargine and lixisenatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE56 |
insulin degludec and liraglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AF |
Insulins and analogues for inhalation
|
Insulines et analogues pour inhalation
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AF01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA |
Biguanides
|
Biguanides
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA01 |
phenformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA02 |
metformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA03 |
buformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB |
Sulfonylureas
|
Sulfonylurées
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB01 |
glibenclamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB02 |
chlorpropamide
|
Chlorpropamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB03 |
tolbutamide
|
Tolbutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB04 |
glibornuride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB05 |
tolazamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB06 |
carbutamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB07 |
glipizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB08 |
gliquidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB09 |
gliclazide
|
Gliclazide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB10 |
metahexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB11 |
glisoxepide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB12 |
glimepiride
|
Glimépiride
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB31 |
acetohexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BC |
Sulfonamides (heterocyclic)
|
Sulfonamides (hétérocycliques)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BC01 |
glymidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD |
Combinations of oral blood glucose lowering drugs
|
Associations de médicaments oraux réduisant la glycémie
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD01 |
phenformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD02 |
metformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD03 |
metformin and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD04 |
glimepiride and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD05 |
metformin and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD06 |
glimepiride and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD07 |
metformin and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD08 |
metformin and vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD09 |
pioglitazone and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD10 |
metformin and saxagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD11 |
metformin and linagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD12 |
pioglitazone and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD13 |
metformin and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD14 |
metformin and repaglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD15 |
metformin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD16 |
metformin and canagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD17 |
metformin and acarbose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD18 |
metformin and gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD19 |
linagliptin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD20 |
metformin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD21 |
saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD22 |
metformin and evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD23 |
metformin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD24 |
sitagliptin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD25 |
metformin, saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF |
Alpha glucosidase inhibitors
|
Inhibteurs d'alpha-glycosidase
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF01 |
acarbose
|
Acarbose
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF02 |
miglitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF03 |
voglibose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG |
Thiazolidinediones
|
Thiazolidinédiones
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG01 |
troglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG02 |
rosiglitazone
|
Rosiglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG03 |
pioglitazone
|
Pioglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH |
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Inhibiteurs de la dipeptidyl peptidase-4 (DPP-4
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH01 |
sitagliptin
|
Sitagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH02 |
vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH03 |
saxagliptin
|
Saxagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH04 |
alogliptin
|
Alogliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH05 |
linagliptin
|
Linagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH06 |
gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH07 |
evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH51 |
sitagliptin and simvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH52 |
gemigliptin and rosuvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ |
Glucagon-like peptide-1 (GLP-1) analogues
|
Analogues du Glucagon-like peptide-1 (GLP-1)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ01 |
exenatide
|
Exénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ02 |
liraglutide
|
Liraglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ03 |
lixisenatide
|
Lixisénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ04 |
albiglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ05 |
dulaglutide
|
Dulaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ06 |
semaglutide
|
Sémaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK |
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
|
Inhibiteurs du Sodium-Glucose Co-Transporteur 2 (SGLT2)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK01 |
dapagliflozin
|
Dapagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK02 |
canagliflozin
|
Canagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK03 |
empagliflozin
|
EMPAGLIFLOZINE
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK04 |
ertugliflozin
|
Ertugliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK05 |
ipragliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK06 |
sotagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX |
Other blood glucose lowering drugs, excl. insulins
|
Autres médicament réduisant la glycémie, autres que les insulines
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX01 |
guar gum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX02 |
repaglinide
|
Répaglinide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX03 |
nateglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX05 |
pramlintide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX06 |
benfluorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX08 |
mitiglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10XA |
Aldose reductase inhibitors
|
Inhibiteurs d'aldose réductase
|
WHO |
Active |
2021-06-09 15:34:07 |
A10XA01 |
tolrestat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA |
Multivitamins with minerals
|
Multivitamines et minéraux
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA01 |
multivitamins and iron
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA02 |
multivitamins and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA03 |
multivitamins and other minerals, incl. combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA04 |
multivitamins and trace elements
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA |
Vitamin A, plain
|
Vitamine A, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA01 |
retinol (vit A)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA02 |
betacarotene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC |
Vitamin D and analogues
|
Vitamine D et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC01 |
ergocalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC02 |
dihydrotachysterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC03 |
alfacalcidol
|
Alfacalcidol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC04 |
calcitriol
|
Calcitriol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC05 |
colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC06 |
calcifediol
|
Calcifédiol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC55 |
colecalciferol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA |
Vitamin B1, plain
|
Vitamine B1, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA01 |
thiamine (vit B1)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA02 |
sulbutiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA03 |
benfotiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GA |
Ascorbic acid (vitamin C), plain
|
Acide ascorbique (vitamine C), non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GA01 |
ascorbic acid (vit C)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GB |
Ascorbic acid (vitamin C), combinations
|
Acide ascorbique (vitamine C), associations
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GB01 |
ascorbic acid (vit C) and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA |
Other plain vitamin preparations
|
Autres préparations à base de vitamines seules
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA01 |
nicotinamide
|
Nicotinamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA02 |
pyridoxine (vit B6)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA03 |
tocopherol (vit E)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA04 |
riboflavin (vit B2)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA05 |
biotin
|
Biotine
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA06 |
pyridoxal phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA07 |
inositol
|
Inositol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA08 |
tocofersolan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA30 |
dexpanthenol
|
Dexpanthénol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA31 |
calcium pantothenate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA32 |
pantethine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA |
Calcium
|
Calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA01 |
calcium phosphate
|
Phosphate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA02 |
calcium glubionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA03 |
calcium gluconate
|
Gluconate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA04 |
calcium carbonate
|
Carbonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA05 |
calcium lactate
|
Lactate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA06 |
calcium lactate gluconate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA08 |
calcium glycerylphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA10 |
calcium glucoheptonate
|
Glucoheptonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA11 |
calcium pangamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA13 |
calcium citrate
|
Citrate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA20 |
calcium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA30 |
calcium laevulate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA |
Potassium
|
Potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA02 |
potassium citrate
|
Citrate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA03 |
potassium hydrogentartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA04 |
potassium hydrogencarbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA05 |
potassium gluconate
|
Gluconate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA30 |
potassium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA51 |
potassium chloride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA |
Sodium
|
Sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA02 |
sodium sulfate
|
Sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB |
Zinc
|
Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB01 |
zinc sulfate
|
Sulfate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB02 |
zinc gluconate
|
Gluconate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC |
Magnesium
|
Magnésium
|
WHO |
Active |
2021-10-25 19:07:15 |
A12CC01 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC02 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC03 |
magnesium gluconate
|
Gluconate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC04 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC05 |
magnesium aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC06 |
magnesium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC07 |
magnesium levulinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC08 |
magnesium pidolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC09 |
magnesium orotate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC10 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC30 |
magnesium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD |
Fluoride
|
Fluorure
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD01 |
sodium fluoride
|
Fluorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD02 |
sodium monofluorophosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD51 |
fluoride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE |
Selenium
|
Sélénium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE01 |
sodium selenate
|
Sélénate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE02 |
sodium selenite
|
Sélénite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA |
Androstan derivatives
|
Dérivés de l'androstane
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA01 |
androstanolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA02 |
stanozolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA03 |
metandienone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA04 |
metenolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA05 |
oxymetholone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA06 |
quinbolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA07 |
prasterone
|
Prastérone
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA08 |
oxandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA09 |
norethandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB |
Estren derivatives
|
Dérivés de l'estrane
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB01 |
nandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB02 |
ethylestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB03 |
oxabolone cipionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA |
Amino acids and derivatives
|
Acides aminés et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA01 |
levocarnitine
|
Lévocarnitine
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA02 |
ademetionine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA03 |
glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA04 |
mercaptamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA05 |
carglumic acid
|
Acide carglumique
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA06 |
betaine
|
Bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA07 |
metreleptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB01 |
alglucerase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB02 |
imiglucerase
|
Imiglucérase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB03 |
agalsidase alfa
|
Agalsidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB04 |
agalsidase beta
|
Agalsidase bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB05 |
laronidase
|
Laronidase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB06 |
sacrosidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB07 |
alglucosidase alfa
|
Alglucosidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB08 |
galsulfase
|
Galsulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB09 |
idursulfase
|
Idursulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB10 |
velaglucerase alfa
|
Vélaglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB11 |
taliglucerase alfa
|
Taliglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB12 |
elosulfase alfa
|
Élosulfase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB13 |
asfotase alfa
|
ASFOTASE ALFA
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB14 |
sebelipase alfa
|
Sébélipase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB15 |
velmanase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB16 |
idursulfase beta
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB17 |
cerliponase alfa
|
Cerliponase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB18 |
vestronidase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB19 |
pegvaliase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX |
Various alimentary tract and metabolism products
|
Produits divers pour le tube digestif et le métabolisme
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX01 |
thioctic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX02 |
anethole trithione
|
Anéthole trithione
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX03 |
sodium phenylbutyrate
|
Phénylbutyrate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX04 |
nitisinone
|
Nitisinone
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX05 |
zinc acetate
|
Acétate de Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX06 |
miglustat
|
Miglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX07 |
sapropterin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX08 |
teduglutide
|
TÉDUGLUTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX09 |
glycerol phenylbutyrate
|
Phénylbutyrate de glycérol
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX10 |
eliglustat
|
Éliglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX11 |
sodium benzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX12 |
trientine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX13 |
uridine triacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX14 |
migalastat
|
Migalastat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX15 |
telotristat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA |
Vitamin K antagonists
|
Antivitamines K
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA01 |
dicoumarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA02 |
phenindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA03 |
warfarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA04 |
phenprocoumon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA07 |
acenocoumarol
|
Acénocoumarol
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA08 |
ethyl biscoumacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA09 |
clorindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA10 |
diphenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA11 |
tioclomarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA12 |
fluindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB |
Heparin group
|
Groupe de l'héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB01 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB02 |
antithrombin III
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB04 |
dalteparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB05 |
Enoxaparin
|
Enoxaparine
|
WHO |
Active |
2021-10-01 12:48:37 |
B01AB06 |
nadroparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB07 |
parnaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB08 |
reviparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB09 |
danaparoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB10 |
tinzaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB11 |
sulodexide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB12 |
bemiparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB51 |
heparin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC |
Platelet aggregation inhibitors excl. heparin
|
Inhibiteurs de l'agrégation plaquettaire, héparine exclue
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC01 |
ditazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC02 |
cloricromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC03 |
picotamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC04 |
clopidogrel
|
Clopidogrel
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC05 |
ticlopidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC06 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC07 |
dipyridamole
|
Dipyridamole
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC08 |
carbasalate calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC09 |
epoprostenol
|
Époprosténol
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC10 |
indobufen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC11 |
iloprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC13 |
abciximab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC15 |
aloxiprin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC16 |
eptifibatide
|
Eptifibatide
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC17 |
tirofiban
|
Tirofiban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC18 |
triflusal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC19 |
beraprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC21 |
treprostinil
|
Tréprostinil
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC22 |
prasugrel
|
Prasugrel
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC23 |
cilostazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC24 |
ticagrelor
|
Ticagrélor
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC25 |
cangrelor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC26 |
vorapaxar
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC27 |
selexipag
|
Sélexipag
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC56 |
acetylsalicylic acid, combinations with proton pump inhibitors
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD01 |
streptokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD02 |
alteplase
|
Altéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD03 |
anistreplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD04 |
urokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD05 |
fibrinolysin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD06 |
brinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD07 |
reteplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD08 |
saruplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD09 |
ancrod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD10 |
drotrecogin alfa (activated)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD11 |
tenecteplase
|
Ténectéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD12 |
protein C
|
Protéine c
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE |
Direct thrombin inhibitors
|
Inhibiteurs directs de la thrombine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE01 |
desirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE02 |
lepirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE03 |
argatroban
|
Argatroban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE04 |
melagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE05 |
ximelagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE06 |
bivalirudin
|
Bivalirudine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE07 |
dabigatran etexilate
|
Dabigatran étexilate
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF |
Direct factor Xa inhibitors
|
Inhibiteurs directs du facteur Xa
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF01 |
rivaroxaban
|
Rivaroxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF02 |
apixaban
|
Apixaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF03 |
edoxaban
|
Édoxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF04 |
betrixaban
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX |
Other antithrombotic agents
|
Autres antithrombotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX01 |
defibrotide
|
DÉFIBROTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX04 |
dermatan sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX05 |
fondaparinux
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX07 |
caplacizumab
|
Caplacizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA01 |
aminocaproic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA02 |
tranexamic acid
|
Acide tranexamique
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA03 |
aminomethylbenzoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB |
Proteinase inhibitors
|
Inhibiteurs de protéinases
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB01 |
aprotinin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB02 |
alfa1 antitrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB04 |
camostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB05 |
ulinastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA |
Vitamin K
|
Vitamine K
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA01 |
phytomenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA02 |
menadione
|
Ménadione
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BB |
Fibrinogen
|
Fibrinogène
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BB01 |
fibrinogen, human
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC |
Local hemostatics
|
Hémostatiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC01 |
absorbable gelatin sponge
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC02 |
oxidized cellulose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC03 |
tetragalacturonic acid hydroxymethylester
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC05 |
adrenalone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC06 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC07 |
collagen
|
Collagène
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC08 |
calcium alginate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC09 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD |
Blood coagulation factors
|
Facteurs de la coagulation sanguine
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD01 |
coagulation factor IX, II, VII and X in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD02 |
coagulation factor VIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD03 |
factor VIII inhibitor bypassing activity
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD04 |
coagulation factor IX
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD05 |
coagulation factor VII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD06 |
von Willebrand factor and coagulation factor VIII in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD07 |
coagulation factor XIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD08 |
coagulation factor VIIa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD10 |
von Willebrand factor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD11 |
catridecacog
|
Catridecacog
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD13 |
coagulation factor X
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD14 |
susoctocog alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD30 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX |
Other systemic hemostatics
|
Autres hémostatiques systémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX01 |
etamsylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX02 |
carbazochrome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX03 |
batroxobin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX04 |
romiplostim
|
Romiplostim
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX05 |
eltrombopag
|
Eltrombopag
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX06 |
emicizumab
|
Émicizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX07 |
lusutrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX08 |
avatrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX09 |
fostamatinib
|
Fostamatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA |
Iron bivalent, oral preparations
|
Fer bivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA01 |
ferrous glycine sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA03 |
ferrous gluconate
|
Gluconate de fer
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA04 |
ferrous carbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA05 |
ferrous chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA06 |
ferrous succinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA07 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA08 |
ferrous tartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA09 |
ferrous aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA10 |
ferrous ascorbate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA11 |
ferrous iodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA12 |
ferrous sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB |
Iron trivalent, oral preparations
|
Fer trivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB01 |
ferric sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB02 |
saccharated iron oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB03 |
sodium feredetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB04 |
ferric hydroxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB05 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB07 |
chondroitin sulfate-iron complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB08 |
ferric acetyl transferrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB09 |
ferric proteinsuccinylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB10 |
ferric maltol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD |
Iron in combination with folic acid
|
Fer en association avec l'acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD01 |
ferrous amino acid complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD03 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD04 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE |
Iron in other combinations
|
Fer dans d'autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE01 |
iron, vitamin B12 and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE02 |
iron, multivitamins and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE03 |
iron and multivitamins
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE04 |
iron, multivitamins and minerals
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE10 |
various combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA |
Vitamin B12 (cyanocobalamin and analogues)
|
Vitamine B12 (cyanocobalamine et dérivés)
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA01 |
cyanocobalamin
|
Cyanocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA02 |
cyanocobalamin tannin complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA03 |
hydroxocobalamin
|
Hydroxocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA04 |
cobamamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA05 |
mecobalamin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA51 |
cyanocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA53 |
hydroxocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB |
Folic acid and derivatives
|
Acide folique et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB01 |
folic acid
|
Acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB51 |
folic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA |
Other antianemic preparations
|
Autres préparations anti-anémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA01 |
erythropoietin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA02 |
darbepoetin alfa
|
Darbépoétine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA03 |
methoxy polyethylene glycol-epoetin beta
|
Méthoxy polyéthylèneglycol-époétine bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA04 |
peginesatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA05 |
roxadustat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA06 |
luspatercept
|
Luspatercept
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA |
Blood substitutes and plasma protein fractions
|
Substituts du sang et fractions protéiques plasmatiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA01 |
albumin
|
Albumine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA02 |
other plasma protein fractions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA03 |
fluorocarbon blood substitutes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA05 |
dextran
|
Dextran
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA06 |
gelatin agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA07 |
hydroxyethylstarch
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA08 |
hemoglobin crosfumaril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA09 |
hemoglobin raffimer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA10 |
hemoglobin glutamer (bovine)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX |
Other blood products
|
Autres dérivés du sang
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX02 |
thrombocytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX03 |
blood plasma
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX04 |
stem cells from umbilical cord blood
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA |
Solutions for parenteral nutrition
|
Solutions pour nutrition parentérale
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA01 |
amino acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA02 |
fat emulsions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA03 |
carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA04 |
protein hydrolysates
|
Hydrolysat protéique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB |
Solutions affecting the electrolyte balance
|
Solutions modifiant le bilan électrolytique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB01 |
electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB02 |
electrolytes with carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB03 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB04 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC |
Solutions producing osmotic diuresis
|
Solutions produisant une diurèse osmotique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC01 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC02 |
carbamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA |
Antiinfectives
|
Anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA01 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA02 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA03 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA04 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA05 |
taurolidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA06 |
mandelic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA07 |
noxytiolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA08 |
ethacridine lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA09 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB |
Salt solutions
|
Solutions salines
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB02 |
sodium citrate
|
Citrate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB03 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB04 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX |
Other irrigating solutions
|
Autres solutions d'irrigation
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX01 |
glucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX02 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX03 |
glycine
|
Glycine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX04 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA |
Electrolyte solutions
|
Solutions d'électrolytes
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA02 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA03 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA04 |
ammonium chloride
|
Chlorure d'ammonium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA05 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA06 |
potassium phosphate, incl. combinations with other potassium salts
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA08 |
sodium acetate
|
Acétate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA09 |
sodium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA10 |
magnesium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA11 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA12 |
zinc chloride
|
Chlorure de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA13 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA14 |
sodium glycerophosphate
|
Glycérophosphate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA15 |
potassium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA16 |
cardioplegia solutions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA17 |
potassium acetate
|
Acétate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA30 |
combinations of electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA31 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB01 |
arginine hydrochloride
|
Chlorhydrate d'arginine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB02 |
alanyl glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB03 |
lysine
|
Lysine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XX |
Other i.v. solution additives
|
Autres additifs pour solutions intraveineuses
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XX02 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA02 |
fibrinolysin and desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA03 |
hyaluronidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA04 |
chymotrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA07 |
trypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA10 |
desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA55 |
streptokinase, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AB |
Heme products
|
Autres médicaments dérivés de l'hème
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AB01 |
hemin
|
Hémine
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC |
Drugs used in hereditary angioedema
|
Autres médicaments utilisés dans l'angio-œdème héréditaire
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC01 |
C1-inhibitor, plasma derived
|
Inhibiteurs C1, dérivés du plasma
|
WHO |
Active |
2021-10-01 12:48:41 |
B06AC02 |
icatibant
|
ICATIBANT
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC03 |
ecallantide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC04 |
conestat alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC05 |
lanadelumab
|
Lanadélumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AX |
Other hematological agents
|
Not found
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AX01 |
crizanlizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA |
Digitalis glycosides
|
Glycosides de la Digitale
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA01 |
acetyldigitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA02 |
acetyldigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA03 |
digitalis leaves
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA04 |
digitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA05 |
digoxin
|
Digoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA06 |
lanatoside C
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA07 |
deslanoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA08 |
metildigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA09 |
gitoformate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA52 |
acetyldigoxin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB |
Scilla glycosides
|
Glycosides de la scille
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB01 |
proscillaridin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB51 |
proscillaridin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC |
Strophanthus glycosides
|
Glycosides du Strophantus
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC01 |
g-strophanthin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC03 |
cymarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AX |
Other cardiac glycosides
|
Autres glycosides cardiotoniques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AX02 |
peruvoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA |
Antiarrhythmics, class Ia
|
Antiarythmiques, classe Ia
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA01 |
quinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA02 |
procainamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA03 |
disopyramide
|
Disopyramide
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA04 |
sparteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA05 |
ajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA08 |
prajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA12 |
lorajmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA13 |
hydroquinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA51 |
quinidine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA71 |
quinidine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB |
Antiarrhythmics, class Ib
|
Antiarythmiques, classe I
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB02 |
mexiletine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB03 |
tocainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB04 |
aprindine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC |
Antiarrhythmics, class Ic
|
Antiarythmiques, classe
|
WHO |
Active |
2021-06-11 15:22:32 |
C01BC03 |
propafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC04 |
flecainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC07 |
lorcainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC08 |
encainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC09 |
ethacizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD |
Antiarrhythmics, class III
|
Antiarythmiques, classe III
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD01 |
amiodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD02 |
bretylium tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD03 |
bunaftine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD04 |
dofetilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD05 |
ibutilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD06 |
tedisamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD07 |
dronedarone
|
Dronédarone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG |
Other antiarrhythmics, class I and III
|
Autres antiarythmiques de classe I et III
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG01 |
moracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG07 |
cibenzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG11 |
vernakalant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA |
Adrenergic and dopaminergic agents
|
Agents adrénergiques et dopaminergique
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA01 |
etilefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA02 |
isoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA03 |
norepinephrine
|
Norépinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA04 |
dopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA05 |
norfenefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA06 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA07 |
dobutamine
|
Dobutamine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA08 |
oxedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA09 |
metaraminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA10 |
methoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA11 |
mephentermine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA12 |
dimetofrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA13 |
prenalterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA14 |
dopexamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA15 |
gepefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA16 |
ibopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA17 |
midodrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA18 |
octopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA19 |
fenoldopam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA21 |
cafedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA22 |
arbutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA23 |
theodrenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA24 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA25 |
amezinium metilsulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA26 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA27 |
droxidopa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE |
Phosphodiesterase inhibitors
|
Inhibiteurs de la phosphodiestéra
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE01 |
amrinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE02 |
milrinone
|
Milrinone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE03 |
enoximone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE04 |
bucladesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX |
Other cardiac stimulants
|
Autres stimulants cardiaque
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX06 |
angiotensinamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX07 |
xamoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX08 |
levosimendan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX09 |
angiotensin II
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA |
Organic nitrates
|
Nitrates organiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA02 |
glyceryl trinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA04 |
methylpropylpropanediol dinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA05 |
pentaerithrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA07 |
propatylnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA08 |
isosorbide dinitrate
|
Dinitrate d'isosorbide
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA09 |
trolnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA13 |
eritrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA14 |
isosorbide mononitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA20 |
organic nitrates in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA38 |
tenitramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA52 |
glyceryl trinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA55 |
pentaerithrityl tetranitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA58 |
isosorbide dinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA70 |
organic nitrates in combination with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DB |
Quinolone vasodilators
|
Vasodilateurs à base de quinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DB01 |
flosequinan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX |
Other vasodilators used in cardiac diseases
|
Autres vasodilateurs utilisés dans des maladies cardiaques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX01 |
itramin tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX02 |
prenylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX03 |
oxyfedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX04 |
benziodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX05 |
carbocromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX06 |
hexobendine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX07 |
etafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX08 |
heptaminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX09 |
imolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX10 |
dilazep
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX11 |
trapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX12 |
molsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX13 |
efloxate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX14 |
cinepazet
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX15 |
cloridarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX16 |
nicorandil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX18 |
linsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX19 |
nesiritide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX21 |
serelaxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX52 |
prenylamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX53 |
oxyfedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EA |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EA01 |
alprostadil
|
Alprostadil
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB |
Other cardiac preparations
|
Autres médicaments pour le cœur
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB02 |
camphora
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB03 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB04 |
crataegus glycosides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB05 |
creatinolfosfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB06 |
fosfocreatine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB07 |
fructose 1,6-diphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB09 |
ubidecarenone
|
Ubidécarénone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB10 |
adenosine
|
Adénosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB11 |
tiracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB13 |
acadesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB15 |
trimetazidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB16 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB17 |
ivabradine
|
Ivabradine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB18 |
ranolazine
|
Ranolazine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB21 |
regadenoson
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB22 |
meldonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB23 |
tiazotic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA |
Rauwolfia alkaloids
|
Alcaloïdes du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA01 |
rescinnamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA02 |
reserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA04 |
rauwolfia alkaloids, whole root
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA05 |
deserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA06 |
methoserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA07 |
bietaserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA52 |
reserpine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB |
Methyldopa
|
Méthyldopa
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB01 |
methyldopa (levorotatory)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB02 |
methyldopa (racemic)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC |
Imidazoline receptor agonists
|
Antagonistes des récepteurs de l'imidazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC01 |
clonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC02 |
guanfacine
|
Guanfacine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC04 |
tolonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC05 |
moxonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC06 |
rilmenidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BA |
Sulfonium derivatives
|
Dérivés du Sulfonium
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BA01 |
trimetaphan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BB |
Secondary and tertiary amines
|
Amines secondaires et tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BB01 |
mecamylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA |
Alpha-adrenoreceptor antagonists
|
Alpha-bloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA01 |
prazosin
|
Prazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA02 |
indoramin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA03 |
trimazosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA04 |
doxazosin
|
Doxazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA06 |
urapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC01 |
betanidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC02 |
guanethidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC03 |
guanoxan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC04 |
debrisoquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC05 |
guanoclor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC06 |
guanazodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC07 |
guanoxabenz
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DA |
Thiazide derivatives
|
Dérivés du thiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DA01 |
diazoxide
|
Diazoxide
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB |
Hydrazinophthalazine derivatives
|
Dérivés de l'hydrazinophtalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB01 |
dihydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB02 |
hydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB03 |
endralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB04 |
cadralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DC |
Pyrimidine derivatives
|
Dérivés de la pyrimidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DC01 |
minoxidil
|
Minoxidil
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DD |
Nitroferricyanide derivatives
|
Dérivés du nitroferricyanure
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DD01 |
nitroprusside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DG |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DG01 |
pinacidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KA |
Alkaloids, excl. rauwolfia
|
Alcaloïdes, autres que ceux du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KA01 |
veratrum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KB |
Tyrosine hydroxylase inhibitors
|
Inhibiteurs de la tyrosine hydroxylase
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KB01 |
metirosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KC |
MAO inhibitors
|
IMAO, inhibiteurs de la monoamino oxydase
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KC01 |
pargyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KD |
Serotonin antagonists
|
Antagonistes de la sérotonine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KD01 |
ketanserin
|
Kétansérine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX |
Antihypertensives for pulmonary arterial hypertension
|
Antihypertenseurs pour l'hypertension artérielle pulmonaire
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX01 |
bosentan
|
Bosentan
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX02 |
ambrisentan
|
Ambrisentan
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX03 |
sitaxentan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX04 |
macitentan
|
MACITENTAN
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX05 |
riociguat
|
RIOCIGUAT
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX52 |
ambrisentan and tadalafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA |
Rauwolfia alkaloids and diuretics in combination
|
Associations d'alcaloïdes du Rauwolfia et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA01 |
reserpine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA02 |
rescinnamine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA03 |
deserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA04 |
methoserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA09 |
syrosingopine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA50 |
combination of rauwolfia alkaloids and diuretics incl. other combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA51 |
reserpine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA52 |
rescinnamine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA71 |
reserpine and diuretics, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LB |
Methyldopa and diuretics in combination
|
Associations de méthyldopa et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LB01 |
methyldopa (levorotatory) and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC |
Imidazoline receptor agonists in combination with diuretics
|
Associations d'antagonistes des récepteurs de l'imidazoline et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC01 |
clonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC05 |
moxonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC51 |
clonidine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LE |
Alpha-adrenoreceptor antagonists and diuretics
|
Associations d'alpha-bloquants et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LE01 |
prazosin and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LF |
Guanidine derivatives and diuretics
|
Associations de dérivés de la guanidine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LF01 |
guanethidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG |
Hydrazinophthalazine derivatives and diuretics
|
Associations de dérivés de la hydrazinophtalazine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG01 |
dihydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG02 |
hydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG51 |
dihydralazine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LL |
MAO inhibitors and diuretics
|
Associations d'IMAO et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LL01 |
pargyline and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA |
Thiazides, plain
|
Thiazidiques non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA01 |
bendroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA02 |
hydroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA03 |
hydrochlorothiazide
|
Hydrochlorothiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA04 |
chlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA05 |
polythiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA06 |
trichlormethiazide
|
Trichlorméthiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA07 |
cyclopenthiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA08 |
methyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA09 |
cyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA13 |
mebutizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB |
Thiazides and potassium in combination
|
Thiazidiques et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB01 |
bendroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB02 |
hydroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB03 |
hydrochlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB04 |
chlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB07 |
cyclopenthiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB09 |
cyclothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AH |
Thiazides, combinations with psycholeptics and/or analgesics
|
Thiazidiques en association avec psycholeptiques et/ou analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AH02 |
hydroflumethiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AX |
Thiazides, combinations with other drugs
|
Thiazidiques en association avec d'autres substances
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AX01 |
hydrochlorothiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA02 |
quinethazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA03 |
clopamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA04 |
chlortalidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA05 |
mefruside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA07 |
clofenamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA08 |
metolazone
|
Métolazone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA09 |
meticrane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA10 |
xipamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA11 |
indapamide
|
Indapamide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA12 |
clorexolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA13 |
fenquizone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB03 |
clopamide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB04 |
chlortalidone and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BC |
Mercurial diuretics
|
Diurétiques mercuriels
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BC01 |
mersalyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BD |
Xanthine derivatives
|
Dérivés xanthiques
|
WHO |
Active |
2021-10-25 19:07:17 |
C03BD01 |
theobromine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BX |
Other low-ceiling diuretics
|
Autres diurétiques low-ceiling
|
WHO |
Active |
2021-10-25 19:07:19 |
C03BX03 |
cicletanine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA01 |
furosemide
|
Furosémide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA02 |
bumetanide
|
Bumétanide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA03 |
piretanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA04 |
torasemide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB01 |
furosemide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB02 |
bumetanide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC |
Aryloxyacetic acid derivatives
|
Dérivés de l'acide aryloxyacétique
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC01 |
etacrynic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC02 |
tienilic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CD |
Pyrazolone derivatives
|
Dérivés de la pyrazolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CD01 |
muzolimine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CX |
Other high-ceiling diuretics
|
Autres diurétiques de l'anse
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CX01 |
etozolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA |
Aldosterone antagonists
|
Antagonistes de l'aldostérone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA01 |
spironolactone
|
Spironolactone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA02 |
potassium canrenoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA03 |
canrenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA04 |
eplerenone
|
Éplérénone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB |
Other potassium-sparing agents
|
Autres diurétiques épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB01 |
amiloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB02 |
triamterene
|
Triamtérène
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA |
Low-ceiling diuretics and potassium-sparing agents
|
Diurétiques low-ceiling et épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA01 |
hydrochlorothiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA02 |
trichlormethiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA03 |
epitizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA04 |
altizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA05 |
mebutizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA06 |
chlortalidone and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA07 |
cyclopenthiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA12 |
metolazone and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA13 |
bendroflumethiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA14 |
butizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB |
High-ceiling diuretics and potassium-sparing agents
|
Diurétiques de l'anse et épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB01 |
furosemide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB02 |
bumetanide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA |
Vasopressin antagonists
|
Antagonistes de la vasopressine
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA01 |
tolvaptan
|
Tolvaptan
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA02 |
conivaptan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA |
2-amino-1-phenylethanol derivatives
|
Dérivés du 2-amino-1-phényléthanol
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA01 |
isoxsuprine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA02 |
buphenine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA31 |
bamethan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB |
Imidazoline derivatives
|
Dérivés de l'imidazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB01 |
phentolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB02 |
tolazoline
|
Tolazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC |
Nicotinic acid and derivatives
|
Acide nicotinique et ses dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC01 |
nicotinic acid
|
Acide nicotinique
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC02 |
nicotinyl alcohol (pyridylcarbinol)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC03 |
inositol nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC07 |
ciclonicate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD |
Purine derivatives
|
Dérivés de la purine
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD01 |
pentifylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD02 |
xantinol nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD03 |
pentoxifylline
|
Pentoxifylline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD04 |
etofylline nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE |
Ergot alkaloids
|
Alcaloïdes de l'ergot de seigle
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE01 |
ergoloid mesylates
|
Mésylates d'ergoloïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE02 |
nicergoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE04 |
dihydroergocristine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE51 |
ergoloid mesylates, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE54 |
dihydroergocristine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AF |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AF01 |
kallidinogenase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX |
Other peripheral vasodilators
|
Autres vasodilatateurs périphériques
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX01 |
cyclandelate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX02 |
phenoxybenzamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX07 |
vincamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX10 |
moxisylyte
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX11 |
bencyclane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX17 |
vinburnine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX19 |
suloctidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX20 |
buflomedil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX21 |
naftidrofuryl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX23 |
butalamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX24 |
visnadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX26 |
cetiedil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX27 |
cinepazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX28 |
ifenprodil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX30 |
azapetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX32 |
fasudil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA |
Corticosteroids
|
Corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA01 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA04 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA05 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA06 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA08 |
fluocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA09 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA10 |
fluocinolone acetonide
|
Acétonide de fluocinolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA11 |
fluocinonide
|
Fluocinonide
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA12 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD |
Local anesthetics
|
Anesthésiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD02 |
tetracaine
|
Tétracaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD03 |
benzocaine
|
Benzocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD04 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD05 |
procaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD06 |
oxetacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD07 |
pramocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE |
Muscle relaxants
|
Myorelaxants
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE01 |
glyceryl trinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE02 |
isosorbide dinitrate
|
Dinitrate d'isosorbide
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE03 |
diltiazem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX |
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
Autres traitements des hémorroïdes et des fissures anales pour usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX01 |
aluminium preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX02 |
bismuth preparations, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX03 |
other preparations, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX04 |
zinc preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX05 |
tribenoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA |
Heparins or heparinoids for topical use
|
Héparines ou héparinoïdes pour usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA01 |
organo-heparinoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA02 |
sodium apolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA03 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA04 |
pentosan polysulfate sodium
|
Pentosane de polysulfate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA51 |
heparinoid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA53 |
heparin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB |
Sclerosing agents for local injection
|
Agents sclérosants pour injection locale
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB01 |
monoethanolamine oleate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB02 |
polidocanol
|
POLIDOCANOL
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB03 |
invert sugar
|
Sucre inverti
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB04 |
sodium tetradecyl sulfate
|
Tétradécyl sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB05 |
phenol
|
Phénol
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB56 |
glucose, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX |
Other sclerosing agents
|
Autres agents sclérosants
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX01 |
calcium dobesilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX51 |
calcium dobesilate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA |
Bioflavonoids
|
Bioflavonoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA01 |
rutoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA02 |
monoxerutin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA03 |
diosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA04 |
troxerutin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA05 |
hidrosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA51 |
rutoside, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA53 |
diosmin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA54 |
troxerutin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX |
Other capillary stabilizing agents
|
Autres stabilisateurs de capillaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX01 |
tribenoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX02 |
naftazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX03 |
Hippocastani semen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA |
Beta blocking agents, non-selective
|
Bêtabloquants non sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA01 |
alprenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA02 |
oxprenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA03 |
pindolol
|
Pindolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA05 |
propranolol
|
Propranolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA06 |
timolol
|
Timolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA07 |
sotalol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA12 |
nadolol
|
Nadolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA14 |
mepindolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA15 |
carteolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA16 |
tertatolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA17 |
bopindolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA19 |
bupranolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA23 |
penbutolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA27 |
cloranolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB |
Beta blocking agents, selective
|
Bêtabloquants sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB01 |
practolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB02 |
metoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB03 |
atenolol
|
Aténolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB04 |
acebutolol
|
Acébutolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB05 |
betaxolol
|
Bétaxolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB06 |
bevantolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB07 |
bisoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB08 |
celiprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB09 |
esmolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB10 |
epanolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB11 |
s-atenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB12 |
nebivolol
|
Nébivolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB13 |
talinolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB14 |
landiolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG |
Alpha and beta blocking agents
|
Alpha et bêtabloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG01 |
labetalol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG02 |
carvedilol
|
Carvédilol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA |
Beta blocking agents, non-selective, and thiazides
|
Bêtabloquants non sélectifs et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA02 |
oxprenolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA05 |
propranolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA06 |
timolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA07 |
sotalol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA12 |
nadolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA68 |
metipranolol and thiazides, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB |
Beta blocking agents, selective, and thiazides
|
Bêtabloquants sélectifs et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB02 |
metoprolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB03 |
atenolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB04 |
acebutolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB06 |
bevantolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB07 |
bisoprolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB12 |
nebivolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB52 |
metoprolol and thiazides, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BG |
Alpha and beta blocking agents and thiazides
|
Alpha et bêtabloquants et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BG01 |
labetalol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA |
Beta blocking agents, non-selective, and other diuretics
|
Bêtabloquants non sélectifs et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA02 |
oxprenolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA03 |
pindolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA17 |
bopindolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA23 |
penbutolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB |
Beta blocking agents, selective, and other diuretics
|
Bêtabloquants sélectifs et autres diurétiques
|
WHO |
Active |
2021-10-25 19:07:21 |
C07CB02 |
metoprolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB03 |
atenolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB53 |
atenolol and other diuretics, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CG |
Alpha and beta blocking agents and other diuretics
|
Alpha et bêtabloquants et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CG01 |
labetalol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DA |
Beta blocking agents, non-selective, thiazides and other diuretics
|
Bêtabloquants non sélectifs, thiazidiques et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DA06 |
timolol, thiazides and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DB |
Beta blocking agents, selective, thiazides and other diuretics
|
Bêtabloquants sélectifs, thiazidiques et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DB01 |
atenolol, thiazides and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB |
Beta blocking agents and calcium channel blockers
|
Bêtabloquants et inhibiteurs du canal de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB02 |
metoprolol and felodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB03 |
atenolol and nifedipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB07 |
bisoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB12 |
nebivolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB13 |
metoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX |
Beta blocking agents, other combinations
|
Bêtabloquants, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX01 |
propranolol and other combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX02 |
sotalol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX03 |
metoprolol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX04 |
bisoprolol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX05 |
metoprolol and ivabradine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX06 |
carvedilol and ivabradine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA |
Dihydropyridine derivatives
|
Dérivés de la dihydropyridine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA01 |
amlodipine
|
Amlodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA02 |
felodipine
|
Félodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA03 |
isradipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA04 |
nicardipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA05 |
nifedipine
|
Nifédipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA06 |
nimodipine
|
Nimodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA07 |
nisoldipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA08 |
nitrendipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA09 |
lacidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA10 |
nilvadipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA11 |
manidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA12 |
barnidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA13 |
lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA14 |
cilnidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA15 |
benidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA16 |
clevidipine
|
Clévidipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA51 |
amlodipine and celecoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA55 |
nifedipine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CX |
Other selective calcium channel blockers with mainly vascular effects
|
Autres inhibiteurs calciques sélectifs à effets vasculaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CX01 |
mibefradil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA |
Phenylalkylamine derivatives
|
Dérivés de la phénylalkylamin
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA01 |
verapamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA02 |
gallopamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA51 |
verapamil, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DB |
Benzothiazepine derivatives
|
Dérivés de la benzothiazépine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DB01 |
diltiazem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA |
Phenylalkylamine derivatives
|
Dérivés de la phénylalkylamine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA01 |
fendiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA02 |
bepridil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX |
Other non-selective calcium channel blockers
|
Autres inhibiteurs calciques non sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX01 |
lidoflazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX02 |
perhexiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA |
Calcium channel blockers and diuretics
|
Inhibiteur calcique et diurétique
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA01 |
nifedipine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA02 |
amlodipine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA |
ACE inhibitors, plain
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène, non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA01 |
captopril
|
Captopril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA02 |
enalapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA03 |
lisinopril
|
Lisinopril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA04 |
perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA05 |
ramipril
|
Ramipril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA06 |
quinapril
|
Quinapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA07 |
benazepril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA08 |
cilazapril
|
Cilazapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA09 |
fosinopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA10 |
trandolapril
|
Trandolapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA11 |
spirapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA12 |
delapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA13 |
moexipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA14 |
temocapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA15 |
zofenopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA16 |
imidapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA |
ACE inhibitors and diuretics
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène et diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA01 |
captopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA02 |
enalapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA03 |
lisinopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA04 |
perindopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA05 |
ramipril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA06 |
quinapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA07 |
benazepril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA08 |
cilazapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA09 |
fosinopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA12 |
delapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA13 |
moexipril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA15 |
zofenopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB |
ACE inhibitors and calcium channel blockers
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène et inhibiteurs du canal du calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB02 |
enalapril and lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB03 |
lisinopril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB04 |
perindopril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB05 |
ramipril and felodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB06 |
enalapril and nitrendipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB07 |
ramipril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB10 |
trandolapril and verapamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB12 |
delapril and manidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX |
ACE inhibitors, other combinations
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX01 |
perindopril, amlodipine and indapamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX02 |
perindopril and bisoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX03 |
ramipril, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX04 |
perindopril, bisoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA |
Angiotensin II receptor blockers (ARBs), plain
|
Antagonistes de l'angiotensine II, non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA01 |
losartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA02 |
eprosartan
|
Éprosartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA03 |
valsartan
|
Valsartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA04 |
irbesartan
|
Irbésartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA05 |
tasosartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA06 |
candesartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA07 |
telmisartan
|
Telmisartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA08 |
olmesartan medoxomil
|
Olmésartan médoxomil
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA09 |
azilsartan medoxomil
|
Azilsartan Médoxomil
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA10 |
fimasartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA |
Angiotensin II receptor blockers (ARBs) and diuretics
|
Antagonistes de l'angiotensine II et diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA01 |
losartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA02 |
eprosartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA03 |
valsartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA04 |
irbesartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA06 |
candesartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA07 |
telmisartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA08 |
olmesartan medoxomil and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA09 |
azilsartan medoxomil and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA10 |
fimasartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB |
Angiotensin II receptor blockers (ARBs) and calcium channel blockers
|
Antagonistes de l'angiotensine II et inhibiteurs du canal de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB01 |
valsartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB02 |
olmesartan medoxomil and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB04 |
telmisartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB05 |
irbesartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB06 |
losartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB07 |
candesartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB08 |
valsartan and lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB09 |
fimasartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX |
Angiotensin II receptor blockers (ARBs), other combinations
|
Antagonistes de l'angiotensine II, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX01 |
valsartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX02 |
valsartan and aliskiren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX03 |
olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX04 |
valsartan and sacubitril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX05 |
valsartan and nebivolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX06 |
candesartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX07 |
irbesartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA |
Renin-inhibitors
|
Inhibiteurs de la rénine
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA01 |
remikiren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA02 |
aliskiren
|
Aliskirène
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA52 |
aliskiren and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA53 |
aliskiren and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA54 |
aliskiren, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA |
HMG CoA reductase inhibitors
|
Inhibiteurs de l'HMG-CoA réductase (statines)
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA01 |
simvastatin
|
Simvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA02 |
lovastatin
|
Lovastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA03 |
pravastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA04 |
fluvastatin
|
Fluvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA05 |
atorvastatin
|
Atorvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA06 |
cerivastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA07 |
rosuvastatin
|
Rosuvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA08 |
pitavastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB |
Fibrates
|
Fibrates
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB01 |
clofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB02 |
bezafibrate
|
Bézafibrate
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB03 |
aluminium clofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB04 |
gemfibrozil
|
Gemfibrozil
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB05 |
fenofibrate
|
Fénofibrate
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB06 |
simfibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB07 |
ronifibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB08 |
ciprofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB09 |
etofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB10 |
clofibride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB11 |
choline fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC |
Bile acid sequestrants
|
Séquestrants d'acides biliaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC01 |
colestyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC02 |
colestipol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC03 |
colextran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC04 |
colesevelam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD |
Nicotinic acid and derivatives
|
Acide nicotiniques et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD01 |
niceritrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD02 |
nicotinic acid
|
Acide nicotinique
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD03 |
nicofuranose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD04 |
aluminium nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD05 |
nicotinyl alcohol (pyridylcarbinol)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD06 |
acipimox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD52 |
nicotinic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX |
Other lipid modifying agents
|
Autres agents réduisant les lipides sériques
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX01 |
dextrothyroxine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX02 |
probucol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX03 |
tiadenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX06 |
omega-3-triglycerides incl. other esters and acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX07 |
magnesium pyridoxal 5-phosphate glutamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX08 |
policosanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX09 |
ezetimibe
|
Ézétimibe
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX10 |
alipogene tiparvovec
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX11 |
mipomersen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX12 |
lomitapide
|
Lomitapide
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX13 |
evolocumab
|
ÉVOLOCUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX14 |
alirocumab
|
Alirocumab
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX15 |
bempedoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA |
Combinations of various lipid modifying agents
|
Inhibiteurs de l'HMG-CoA réductase en association avec d'autres modificateurs des lipides
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA01 |
lovastatin and nicotinic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA02 |
simvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA03 |
pravastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA04 |
simvastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA05 |
atorvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA06 |
rosuvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA07 |
rosuvastatin and omega-3 fatty acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA08 |
atorvastatin and omega-3 fatty acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA09 |
rosuvastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX |
Lipid modifying agents in combination with other drugs
|
Inhibiteurs de l'HMG-CoA réductase, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX01 |
simvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX02 |
pravastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX03 |
atorvastatin and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX04 |
simvastatin, acetylsalicylic acid and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX05 |
rosuvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX06 |
atorvastatin, acetylsalicylic acid and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX07 |
rosuvastatin, amlodipine and lisinopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX08 |
atorvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX09 |
rosuvastatin and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX10 |
rosuvastatin and valsartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX11 |
atorvastatin, amlodipine and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX12 |
atorvastatin, acetylsalicylic acid and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX13 |
rosuvastatin, perindopril and indapamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX14 |
rosuvastatin, amlodipine and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX15 |
atorvastatin and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX16 |
rosuvastatin and fimasartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX17 |
rosuvastatin and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA |
Antibiotics
|
Antibiotiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA01 |
nystatin
|
Nystatine
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA02 |
natamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA03 |
hachimycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA04 |
pecilocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA06 |
mepartricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA07 |
pyrrolnitrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA08 |
griseofulvin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC |
Imidazole and triazole derivatives
|
Dérivés imidazolés et triazolés à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC01 |
clotrimazole
|
Clotrimazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC02 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC03 |
econazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC04 |
chlormidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC05 |
isoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC06 |
tiabendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC07 |
tioconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC08 |
ketoconazole
|
Kétoconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC09 |
sulconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC10 |
bifonazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC11 |
oxiconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC12 |
fenticonazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC13 |
omoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC14 |
sertaconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC15 |
fluconazole
|
Fluconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC16 |
flutrimazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC17 |
eberconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC18 |
luliconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC19 |
efinaconazole
|
Éfinaconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC20 |
imidazoles/triazoles in combination with corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC52 |
miconazole, combinations
|
|